Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4061653
Max Phase: Preclinical
Molecular Formula: C19H20N2
Molecular Weight: 276.38
Molecule Type: Small molecule
Associated Items:
ID: ALA4061653
Max Phase: Preclinical
Molecular Formula: C19H20N2
Molecular Weight: 276.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: c1ccc(CNC2CCc3c([nH]c4ccccc34)C2)cc1
Standard InChI: InChI=1S/C19H20N2/c1-2-6-14(7-3-1)13-20-15-10-11-17-16-8-4-5-9-18(16)21-19(17)12-15/h1-9,15,20-21H,10-13H2
Standard InChI Key: KMOKEVFNTNVAQP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 276.38 | Molecular Weight (Monoisotopic): 276.1626 | AlogP: 3.82 | #Rotatable Bonds: 3 |
Polar Surface Area: 27.82 | Molecular Species: BASE | HBA: 1 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.67 | CX LogP: 3.88 | CX LogD: 1.65 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.75 | Np Likeness Score: -0.45 |
1. Kulkarni MR, Mane MS, Ghosh U, Sharma R, Lad NP, Srivastava A, Kulkarni-Almeida A, Kharkar PS, Khedkar VM, Pandit SS.. (2017) Discovery of tetrahydrocarbazoles as dual pERK and pRb inhibitors., 134 [PMID:28431342] [10.1016/j.ejmech.2017.02.062] |
Source(1):